Peter Donnan

Academic, Professor (Teaching and Research) of Epidemiology and Biostatistics

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Donnan is a Professor of Teaching and Research in Epidemiology and Biostatistics at the University of Dundee, UK. His research focuses on various aspects of public health, including antibiotic prescribing patterns, remote monitoring for chemotherapy, and the genetic factors affecting physical performance and muscle mass. He has contributed extensively to studies on cancer outcomes, risk prediction, and healthcare management during the COVID-19 pandemic.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Bruce Guthrie

Professor of General Practice and Director Advanced Care Research Centre

University of Edinburgh

UNITED KINGDOM

Peter Donnan

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Antibiotic prescribing for care-home residents: a population-based, cross-classified multilevel analysis in Scotland, UK

The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis

Patients’ and Clinicians’ Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews

Community antibiotic prescribing in patients with COVID-19 across three pandemic waves

iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment

Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass

Death from cancer

Multicenter Randomized Trial Assessing MRI and Image-guided Biopsy for Suspected Prostate Cancer: The MULTIPROS Study

External validation of the QLifetime cardiovascular risk prediction tool

Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity

Patients’ and clinicians’ experiences using ASyMS, a real-time remote monitoring system for chemotherapy symptom management: Qualitative study (Preprint)

Age and cancer type

Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia – analyses from the LACE randomised controlled trial

Hidden pain and palliative care in general practice out-of-hours attendances by patients with advanced cancer: an analysis of coded and uncoded free-text data

Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood

Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT

Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture

Patient outcomes following AKI and AKD

Community prescribing trends and prevalence in the last year of life, for people who die from cancer

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity

Collaborators (22)

Bruce Guthrie

Charis Marwick

Clare J Taylor

Peter 't Hoen

Jacob George

John Dillon

Geir V. Berg

Rachael Barrett

Julie Whitney

Benjamin Parcell

Grigorios Kotronoulas

Lisa McCann

Huan Wang

Alexander Doney

Emma Ream

Ify Mordi

Jo Armes

Gabriel Rogers

Miles Witham

Sundararajan Srinivasan

Jenny Harris

Christine Miaskowski

Make your next move.